POET Stock: The Cash, the Hurdles and the Math

POET Technologies: The Cash, the Hurdles and the Math

POET Technologies $POET traded $6.65 Monday morning, 68% below the $20.81 it printed in May. Optical stocks got hulk-smashed last week and the small caps didn't bounce with the big ones. We've written a lot of POET copy this year. This piece is different. It's the case for, the case against, and the one number that sits between them. No price target. The math is more useful than one, and it's all here.

The cash

Start with the balance sheet, because everything else hangs off it. POET ended June with $796.3 million in cash and short-term investments. At $6.65 the market cap is about $1.15 billion. So cash is roughly 69% of the cap, about $4.60 a share on the basic count, and the market is paying something like $355 million for everything that isn't cash: the technology, the patents, the customer framework and the capacity build. That's before Q3 burn, which we'll get to.

We can't find a loan on the other side of it. Finance costs in the quarter were $68,000, lease-level money, not interest on borrowings. For a company that hasn't shipped at volume, that's rare.

The burn, which is the run rate that matters

Revenue is tiny. Q2 was $569,925. Annualize it and you get about $2.3 million against a $1.15 billion cap, which is the number the bears lead with, and they're right to. The run rate that matters here is the burn. Operating cash outflow was $12.2 million in Q2. POET's own deck projects about $15 million a quarter plus roughly $60 million of 2026 capex. Call it $120 million a year all-in. That's six-plus years of runway on June's cash, and thirteen on operating burn alone.

Nobody's selling stock into a 5% rate tape to keep the lights on. Applied Optoelectronics $AAOI put a $600 million at-the-market program on the sector in August. Aeva $AEVA sold $115 million of stock in June. POET raised before it needed to, which is the whole difference between a funded ramp and a hopeful one.

Money for the mandate

The $400 million raised in May had a specific job: a roughly ten-fold expansion of manufacturing capacity, in the company's own use-of-proceeds language. The AGM target is capacity of up to one million units a month by the end of 2027. Most pre-revenue hardware companies promise capacity, then raise money to build it. POET did it in the other order. The raise came at a premium to market from a single institutional investor, and the CEO said it removes the uncertainty about the company's staying power. His words, not ours.

The market POET is building for isn't the question either. Lumentum $LITE says its optical parts are sold out through early 2029, and Coherent $COHR just posted a record year. Demand for light isn't what's being debated. Whether POET's engines get qualified into that demand is.

What's actually signed

One dollarized commitment exists, and we're going to be precise about it because loose language has hurt this stock before. Lumilens placed a $50 million initial purchase order under a framework that can reach $500 million over five years. Lumilens itself came out of stealth in August with a $700 million-plus Series C at a $5.5 billion valuation, so the customer is funded too.

Beyond that, the September deck names Mitsubishi for 1.6T engines, NTT for 1.6T and 3.2T work plus 100G BiDi, Adtran for edge optics, and Lessengers. The AGM cited more than ten active engagements expected to exceed $100 million in future annual revenue. Engagements aren't orders, and we won't call them orders. In April, Marvell $MRVL cancelled a POET purchase order tied to its Celestial AI acquisition. The company announced the cancellation without disclosing the order's size, and the stock gave up close to a billion dollars of market value in a session on the information gap. That precedent is why “confirmed customer orders” doesn't appear in our copy for anything that isn't Lumilens.

The three hurdles we can't argue away

An independent deep-dive video making the rounds frames POET as interesting but gated by three things: customer qualification, margin at volume, and repeat orders. That's the right exam, so we'll grade it honestly.

Qualification: the Q2 release says production units for qualification ship in the remaining 2026 quarters, and the cash means POET can sit through a long qualification cycle without going back to the market. Repeat orders: the Lumilens framework is the structure for them, but a framework is a ceiling, not a floor, and the only number that's landed is the $50 million initial PO. Margin at volume: nobody knows yet, including us. POET hasn't shipped at volume, so there's no gross margin to analyze. That one stays open until it doesn't.

The dilution nobody should skip

The clean cash number has a messy cap table behind it. Basic shares are about 173 million. Fully diluted, the September deck shows roughly 264 million: about 79 million warrants at an average strike near $4.39, 5.4 million options at $2.10, and 7 million RSUs. At $6.65 most of those warrants are in the money. Exercise brings cash in, which is the good news, and brings shares out, which is the overhang. Cash-per-share math on 173 million shares flatters POET. On 264 million it's about $3.00 a share before any exercise proceeds. The honest number sits between those two and moves with the stock.

The tape

The stock is under $7 and under its 200-day average. The disclosure calendar runs light between catalysts, and markets fill quiet with their own stories. Six straight quarters of sequential revenue growth through Q2 is real, but at these dollar amounts it's a trend, not a business yet. The next scheduled proof point is the Q3 report in November. Last year's came November 13. Headcount went from 115 in May to 155 in August, the board added two directors with deep photonics and licensing backgrounds, and the patent count stands at 49 granted and 37 pending. Those are the things a company does when it expects to ship. It isn't shipping at volume yet.

The math is the point

We're not putting a price target on this. What's above is worth more than a target because every piece of it can be checked against the filings: $796 million of cash, $12 million of quarterly burn, 173 million basic shares, 264 million diluted, one $50 million order inside a $500 million framework, and three hurdles with one of them unanswerable today. Build your own number from those inputs. It'll be one you can defend.

Subscribe to StockAlpha.ai for the next POET read.